Trial Outcomes & Findings for Long Duration Activity and Metabolic Control After Spinal Cord Injury (NCT NCT03139344)
NCT ID: NCT03139344
Last Updated: 2023-02-16
Results Overview
Acute post-stimulation effect upon skeletal muscle nuclear receptor subfamily 4 group A member 3 (NR4A3) expression, measured via muscle biopsy and exon array analysis. Probe summarization and probe set normalization were performed using robust multichip average, which included background correction, quantile normalization, log2 transformation and median polish probe set summarization. 0 represents no mRNA expression and higher values represent greater expression compared to all genes in the microarray.
COMPLETED
NA
89 participants
3 hours after a single session of electrical stimulation
2023-02-16
Participant Flow
Participant milestones
| Measure |
Acute Gene Regulation: Low Frequency
Adaptations in gene regulation in response to single-session low-frequency exercise.
Low-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of low-frequency electrical stimulation.
|
Acute Gene Regulation: High Frequency
Adaptations in gene regulation in response to single-session high-frequency exercise.
High-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of high-frequency electrical stimulation.
|
Training Study: Low Frequency
Adaptations in gene regulation, systemic metabolic markers, and patient-report metrics in response to training with low-frequency exercise.
Low-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of low-frequency electrical stimulation.
|
Training Study: High Frequency
Adaptations in gene regulation in response to training with high-frequency exercise.
High-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of high-frequency electrical stimulation.
|
Comparator Cohort
Participants will undergo selected outcome measures to provide comparison values for Experimental arms.
|
|---|---|---|---|---|---|
|
Overall Study
STARTED
|
28
|
12
|
21
|
10
|
18
|
|
Overall Study
COMPLETED
|
28
|
12
|
21
|
10
|
18
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
0
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Long Duration Activity and Metabolic Control After Spinal Cord Injury
Baseline characteristics by cohort
| Measure |
Acute Gene Regulation: Low Frequency
n=28 Participants
Adaptations in gene regulation in response to single-session low-frequency exercise.
Low-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of low-frequency electrical stimulation.
|
Acute Gene Regulation: High Frequency
n=12 Participants
Adaptations in gene regulation in response to single-session high-frequency exercise.
High-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of high-frequency electrical stimulation.
|
Training Study: Low Frequency
n=21 Participants
Adaptations in gene regulation, systemic metabolic markers, and patient-report metrics in response to training with low-frequency exercise.
Low-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of low-frequency electrical stimulation.
|
Training Study: High Frequency
n=10 Participants
Adaptations in gene regulation in response to training with high-frequency exercise.
High-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of high-frequency electrical stimulation.
|
Comparator Cohort
n=18 Participants
Participants will undergo selected outcome measures to provide comparison values for Experimental arms.
|
Total
n=89 Participants
Total of all reporting groups
|
|---|---|---|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
0 Participants
n=8 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
28 Participants
n=5 Participants
|
12 Participants
n=7 Participants
|
21 Participants
n=5 Participants
|
10 Participants
n=4 Participants
|
18 Participants
n=21 Participants
|
89 Participants
n=8 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
0 Participants
n=8 Participants
|
|
Sex: Female, Male
Female
|
10 Participants
n=5 Participants
|
4 Participants
n=7 Participants
|
8 Participants
n=5 Participants
|
3 Participants
n=4 Participants
|
4 Participants
n=21 Participants
|
29 Participants
n=8 Participants
|
|
Sex: Female, Male
Male
|
18 Participants
n=5 Participants
|
8 Participants
n=7 Participants
|
13 Participants
n=5 Participants
|
7 Participants
n=4 Participants
|
14 Participants
n=21 Participants
|
60 Participants
n=8 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
1 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
1 Participants
n=21 Participants
|
2 Participants
n=8 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
27 Participants
n=5 Participants
|
12 Participants
n=7 Participants
|
21 Participants
n=5 Participants
|
10 Participants
n=4 Participants
|
17 Participants
n=21 Participants
|
87 Participants
n=8 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
0 Participants
n=8 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
1 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
1 Participants
n=8 Participants
|
|
Race (NIH/OMB)
Asian
|
2 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
2 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
4 Participants
n=8 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
0 Participants
n=8 Participants
|
|
Race (NIH/OMB)
Black or African American
|
2 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
1 Participants
n=21 Participants
|
5 Participants
n=8 Participants
|
|
Race (NIH/OMB)
White
|
23 Participants
n=5 Participants
|
11 Participants
n=7 Participants
|
18 Participants
n=5 Participants
|
10 Participants
n=4 Participants
|
17 Participants
n=21 Participants
|
79 Participants
n=8 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
0 Participants
n=8 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
0 Participants
n=8 Participants
|
|
Region of Enrollment
United States
|
28 participants
n=5 Participants
|
12 participants
n=7 Participants
|
21 participants
n=5 Participants
|
10 participants
n=4 Participants
|
18 participants
n=21 Participants
|
89 participants
n=8 Participants
|
|
Quadriplegia versus Paraplegia
Quadriplegia
|
8 Participants
n=5 Participants
|
4 Participants
n=7 Participants
|
6 Participants
n=5 Participants
|
2 Participants
n=4 Participants
|
6 Participants
n=21 Participants
|
26 Participants
n=8 Participants
|
|
Quadriplegia versus Paraplegia
Paraplegia
|
20 Participants
n=5 Participants
|
8 Participants
n=7 Participants
|
15 Participants
n=5 Participants
|
8 Participants
n=4 Participants
|
12 Participants
n=21 Participants
|
63 Participants
n=8 Participants
|
PRIMARY outcome
Timeframe: 3 hours after a single session of electrical stimulationPopulation: This outcome measure only pertains to the single-session (3 hour) study arms: Acute Gene Regulation: Low Frequency and Acute Gene Regulation: High Frequency
Acute post-stimulation effect upon skeletal muscle nuclear receptor subfamily 4 group A member 3 (NR4A3) expression, measured via muscle biopsy and exon array analysis. Probe summarization and probe set normalization were performed using robust multichip average, which included background correction, quantile normalization, log2 transformation and median polish probe set summarization. 0 represents no mRNA expression and higher values represent greater expression compared to all genes in the microarray.
Outcome measures
| Measure |
Acute Gene Regulation: Low Frequency
n=28 Participants
Adaptations in gene regulation in response to single-session low-frequency exercise.
Low-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of low-frequency electrical stimulation.
|
Acute Gene Regulation: High Frequency
n=12 Participants
Adaptations in gene regulation in response to single-session high-frequency exercise.
High-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of high-frequency electrical stimulation.
|
|---|---|---|
|
Acute Gene Regulation: NR4A3 mRNA Expression Pre and Post-Stimulation
Pre-Stimulation
|
3.235 arbitrary units
Standard Deviation 0.81
|
2.711 arbitrary units
Standard Deviation 0.49
|
|
Acute Gene Regulation: NR4A3 mRNA Expression Pre and Post-Stimulation
Post-Stimulation
|
6.286 arbitrary units
Standard Deviation 0.78
|
5.772 arbitrary units
Standard Deviation 0.49
|
PRIMARY outcome
Timeframe: 3 hours after a single session of electrical stimulationPopulation: This outcome measure only pertains to the single-session (3 hour) study arms: Acute Gene Regulation: Low Frequency and Acute Gene Regulation: High Frequency
Acute post-stimulation effect upon skeletal muscle peroxisome proliferator-activated gamma coactivator (PGC1-alpha) expression, measured via muscle biopsy and exon array analysis. Probe summarization and probe set normalization were performed using robust multichip average, which included background correction, quantile normalization, log2 transformation and median polish probe set summarization. 0 represents no mRNA expression and higher values represent greater expression compared to all genes in the microarray.
Outcome measures
| Measure |
Acute Gene Regulation: Low Frequency
n=28 Participants
Adaptations in gene regulation in response to single-session low-frequency exercise.
Low-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of low-frequency electrical stimulation.
|
Acute Gene Regulation: High Frequency
n=12 Participants
Adaptations in gene regulation in response to single-session high-frequency exercise.
High-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of high-frequency electrical stimulation.
|
|---|---|---|
|
Acute Gene Regulation: PGC1-alpha mRNA Expression Pre and Post-Stimulation
Pre-Stimulation
|
5.37 arbitrary units
Standard Deviation 0.48
|
4.92 arbitrary units
Standard Deviation 0.30
|
|
Acute Gene Regulation: PGC1-alpha mRNA Expression Pre and Post-Stimulation
Post-Stimulation
|
6.72 arbitrary units
Standard Deviation 0.39
|
6.43 arbitrary units
Standard Deviation 0.30
|
PRIMARY outcome
Timeframe: 3 hours after a single session of electrical stimulationPopulation: This outcome measure only pertains to the single-session (3 hour) study arms: Acute Gene Regulation: Low Frequency and Acute Gene Regulation: High Frequency
Acute post-stimulation effect upon skeletal muscle actin binding Rho activating protein (ABRA) expression, measured via muscle biopsy and exon array analysis. Probe summarization and probe set normalization were performed using robust multichip average, which included background correction, quantile normalization, log2 transformation and median polish probe set summarization. 0 represents no mRNA expression and higher values represent greater expression compared to all genes in the microarray.
Outcome measures
| Measure |
Acute Gene Regulation: Low Frequency
n=28 Participants
Adaptations in gene regulation in response to single-session low-frequency exercise.
Low-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of low-frequency electrical stimulation.
|
Acute Gene Regulation: High Frequency
n=12 Participants
Adaptations in gene regulation in response to single-session high-frequency exercise.
High-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of high-frequency electrical stimulation.
|
|---|---|---|
|
Acute Gene Regulation: ABRA mRNA Expression Pre and Post-Stimulation
Pre-Stimulation
|
6.76 arbitrary units
Standard Deviation 0.993
|
5.63 arbitrary units
Standard Deviation 0.34
|
|
Acute Gene Regulation: ABRA mRNA Expression Pre and Post-Stimulation
Post-Stimulation
|
8.61 arbitrary units
Standard Deviation 0.76
|
7.71 arbitrary units
Standard Deviation 0.34
|
PRIMARY outcome
Timeframe: 3 hours after a single session of electrical stimulationPopulation: This outcome measure only pertains to the single-session (3 hour) study arms: Acute Gene Regulation: Low Frequency and Acute Gene Regulation: High Frequency
Acute post-stimulation effect upon skeletal muscle pyruvate dehydrogenase kinase 4 (PDK4) expression, measured via muscle biopsy and exon array analysis. Probe summarization and probe set normalization were performed using robust multichip average, which included background correction, quantile normalization, log2 transformation and median polish probe set summarization. 0 represents no mRNA expression and higher values represent greater expression compared to all genes in the microarray.
Outcome measures
| Measure |
Acute Gene Regulation: Low Frequency
n=28 Participants
Adaptations in gene regulation in response to single-session low-frequency exercise.
Low-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of low-frequency electrical stimulation.
|
Acute Gene Regulation: High Frequency
n=12 Participants
Adaptations in gene regulation in response to single-session high-frequency exercise.
High-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of high-frequency electrical stimulation.
|
|---|---|---|
|
Acute Gene Regulation: PDK4 mRNA Expression Pre and Post-Stimulation
Pre-Stimulation
|
6.64 arbitrary units
Standard Deviation 0.38
|
6.46 arbitrary units
Standard Deviation 0.44
|
|
Acute Gene Regulation: PDK4 mRNA Expression Pre and Post-Stimulation
Post-Stimulation
|
7.23 arbitrary units
Standard Deviation 0.38
|
7.45 arbitrary units
Standard Deviation 0.44
|
PRIMARY outcome
Timeframe: 6 monthsPopulation: This outcome measure only pertains to the Training study arms: Training Study: Low Frequency and Training Study: High Frequency.
Pre- and post-training skeletal muscle myosin heavy chain 6 (MYH6) expression, measured via muscle biopsy and exon array analysis. Probe summarization and probe set normalization were performed using robust multichip average, which included background correction, quantile normalization, log2 transformation and median polish probe set summarization. 0 represents no mRNA expression and higher values represent greater expression compared to all genes in the microarray.
Outcome measures
| Measure |
Acute Gene Regulation: Low Frequency
n=21 Participants
Adaptations in gene regulation in response to single-session low-frequency exercise.
Low-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of low-frequency electrical stimulation.
|
Acute Gene Regulation: High Frequency
n=10 Participants
Adaptations in gene regulation in response to single-session high-frequency exercise.
High-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of high-frequency electrical stimulation.
|
|---|---|---|
|
Post-training Gene Regulation: MYH6 mRNA Expression Baseline and Post-Training
Baseline
|
6.61 arbitrary units
Standard Deviation 0.71
|
5.38 arbitrary units
Standard Deviation 0.69
|
|
Post-training Gene Regulation: MYH6 mRNA Expression Baseline and Post-Training
Post-Training
|
7.10 arbitrary units
Standard Deviation 0.88
|
6.58 arbitrary units
Standard Deviation 0.69
|
PRIMARY outcome
Timeframe: 6 monthsPopulation: This outcome measure only pertains to the Training study arms: Training Study: Low Frequency and Training Study: High Frequency.
Pre- and post-training skeletal muscle myosin light chain 3 (MYL3) expression, measured via muscle biopsy and exon array analysis. Probe summarization and probe set normalization were performed using robust multichip average, which included background correction, quantile normalization, log2 transformation and median polish probe set summarization. 0 represents no mRNA expression and higher values represent greater expression compared to all genes in the microarray.
Outcome measures
| Measure |
Acute Gene Regulation: Low Frequency
n=21 Participants
Adaptations in gene regulation in response to single-session low-frequency exercise.
Low-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of low-frequency electrical stimulation.
|
Acute Gene Regulation: High Frequency
n=10 Participants
Adaptations in gene regulation in response to single-session high-frequency exercise.
High-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of high-frequency electrical stimulation.
|
|---|---|---|
|
Post-training Gene Regulation: MYL3 mRNA Expression Baseline and Post-Training
Post-Training
|
8.01 arbitrary units
Standard Deviation 1.08
|
7.96 arbitrary units
Standard Deviation 0.81
|
|
Post-training Gene Regulation: MYL3 mRNA Expression Baseline and Post-Training
Baseline
|
7.37 arbitrary units
Standard Deviation 0.87
|
6.38 arbitrary units
Standard Deviation 0.81
|
PRIMARY outcome
Timeframe: 6 monthsPopulation: This outcome measure only pertains to the Training study arms: Training Study: Low Frequency and Training Study: High Frequency.
Pre- and post-training skeletal muscle myosin heavy chain 7 (MYH7) expression, measured via muscle biopsy and exon array analysis. Probe summarization and probe set normalization were performed using robust multichip average, which included background correction, quantile normalization, log2 transformation and median polish probe set summarization. 0 represents no mRNA expression and higher values represent greater expression compared to all genes in the microarray.
Outcome measures
| Measure |
Acute Gene Regulation: Low Frequency
n=21 Participants
Adaptations in gene regulation in response to single-session low-frequency exercise.
Low-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of low-frequency electrical stimulation.
|
Acute Gene Regulation: High Frequency
n=10 Participants
Adaptations in gene regulation in response to single-session high-frequency exercise.
High-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of high-frequency electrical stimulation.
|
|---|---|---|
|
Post-training Gene Regulation: MYH7 mRNA Expression Baseline and Post-Training
Baseline
|
8.55 arbitrary units
Standard Deviation 1.1
|
7.16 arbitrary units
Standard Deviation 0.88
|
|
Post-training Gene Regulation: MYH7 mRNA Expression Baseline and Post-Training
Post-Training
|
9.43 arbitrary units
Standard Deviation 1.4
|
8.85 arbitrary units
Standard Deviation 0.88
|
PRIMARY outcome
Timeframe: 6 monthsPopulation: This outcome measure only pertains to the Training study arms: Training Study: Low Frequency and Training Study: High Frequency.
Pre- and post-training skeletal muscle actin 3 (ACTN3) expression, measured via muscle biopsy and exon array analysis. Probe summarization and probe set normalization were performed using robust multichip average, which included background correction, quantile normalization, log2 transformation and median polish probe set summarization. 0 represents no mRNA expression and higher values represent greater expression compared to all genes in the microarray.
Outcome measures
| Measure |
Acute Gene Regulation: Low Frequency
n=21 Participants
Adaptations in gene regulation in response to single-session low-frequency exercise.
Low-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of low-frequency electrical stimulation.
|
Acute Gene Regulation: High Frequency
n=10 Participants
Adaptations in gene regulation in response to single-session high-frequency exercise.
High-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of high-frequency electrical stimulation.
|
|---|---|---|
|
Post-training Gene Regulation: ACTN3 mRNA Expression Baseline and Post-Training
Baseline
|
8.95 arbitrary units
Standard Deviation 0.79
|
8.51 arbitrary units
Standard Deviation 0.74
|
|
Post-training Gene Regulation: ACTN3 mRNA Expression Baseline and Post-Training
Post-Training
|
8.20 arbitrary units
Standard Deviation 0.71
|
7.12 arbitrary units
Standard Deviation 0.74
|
PRIMARY outcome
Timeframe: 6 monthsPopulation: This outcome measure only pertains to the Training Study: Low Frequency arm. 11 participants contributed venous blood samples.
Pre- and post-training fasting insulin, measured via venipuncture and standard laboratory assays
Outcome measures
| Measure |
Acute Gene Regulation: Low Frequency
n=11 Participants
Adaptations in gene regulation in response to single-session low-frequency exercise.
Low-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of low-frequency electrical stimulation.
|
Acute Gene Regulation: High Frequency
Adaptations in gene regulation in response to single-session high-frequency exercise.
High-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of high-frequency electrical stimulation.
|
|---|---|---|
|
Post-training Metabolism: Fasting Insulin
Pre-Training
|
19.245 microU/mL
Standard Deviation 16.387
|
—
|
|
Post-training Metabolism: Fasting Insulin
Post-Training
|
8.305 microU/mL
Standard Deviation 3.407
|
—
|
PRIMARY outcome
Timeframe: 6 monthsPopulation: This outcome measure only pertains to the Training Study: Low Frequency arm. 11 participants contributed venous blood samples.
Pre- and post-training fasting glucose, measured via venipuncture and standard laboratory assays
Outcome measures
| Measure |
Acute Gene Regulation: Low Frequency
n=11 Participants
Adaptations in gene regulation in response to single-session low-frequency exercise.
Low-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of low-frequency electrical stimulation.
|
Acute Gene Regulation: High Frequency
Adaptations in gene regulation in response to single-session high-frequency exercise.
High-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of high-frequency electrical stimulation.
|
|---|---|---|
|
Post-training Metabolism: Fasting Glucose
Pre-Training
|
94.727 mg/dL
Standard Deviation 10.725
|
—
|
|
Post-training Metabolism: Fasting Glucose
Post-Training
|
91.091 mg/dL
Standard Deviation 14.223
|
—
|
PRIMARY outcome
Timeframe: 6 monthsPopulation: This outcome measure only pertains to the Training Study: Low Frequency arm. 11 participants contributed venous blood samples.
Pre- and post-training ratio of fasting glucose to fasting insulin, measured via venipuncture and standard laboratory assays
Outcome measures
| Measure |
Acute Gene Regulation: Low Frequency
n=11 Participants
Adaptations in gene regulation in response to single-session low-frequency exercise.
Low-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of low-frequency electrical stimulation.
|
Acute Gene Regulation: High Frequency
Adaptations in gene regulation in response to single-session high-frequency exercise.
High-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of high-frequency electrical stimulation.
|
|---|---|---|
|
Post-training Metabolism: Fasting Glucose-insulin Ratio
Pre-Training
|
8.649 ratio
Standard Deviation 5.573
|
—
|
|
Post-training Metabolism: Fasting Glucose-insulin Ratio
Post-Training
|
11.274 ratio
Standard Deviation 5.417
|
—
|
PRIMARY outcome
Timeframe: 6 monthsPopulation: This outcome measure only pertains to the Training Study: Low Frequency arm. 11 participants contributed venous blood samples.
Pre- and post-training fasting Hemoglobin A1C (HbA1c), measured via venipuncture and standard laboratory assays
Outcome measures
| Measure |
Acute Gene Regulation: Low Frequency
n=11 Participants
Adaptations in gene regulation in response to single-session low-frequency exercise.
Low-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of low-frequency electrical stimulation.
|
Acute Gene Regulation: High Frequency
Adaptations in gene regulation in response to single-session high-frequency exercise.
High-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of high-frequency electrical stimulation.
|
|---|---|---|
|
Post-training Metabolism: Fasting Hemoglobin A1c (HBA1c)
Pre-training
|
4.227 percent of total hemoglobin
Standard Deviation 1.030
|
—
|
|
Post-training Metabolism: Fasting Hemoglobin A1c (HBA1c)
Post-training
|
3.970 percent of total hemoglobin
Standard Deviation 0.946
|
—
|
PRIMARY outcome
Timeframe: 6 monthsPopulation: This outcome measure only pertains to the Training Study: Low Frequency arm. 11 participants contributed venous blood samples.
Pre- and post-training C-reactive protein (CRP), measured via venipuncture and standard laboratory assays
Outcome measures
| Measure |
Acute Gene Regulation: Low Frequency
n=11 Participants
Adaptations in gene regulation in response to single-session low-frequency exercise.
Low-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of low-frequency electrical stimulation.
|
Acute Gene Regulation: High Frequency
Adaptations in gene regulation in response to single-session high-frequency exercise.
High-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of high-frequency electrical stimulation.
|
|---|---|---|
|
Post-training Metabolism: C-reactive Protein (CRP)
Pre-training
|
11.427 mg/L
Standard Deviation 11.137
|
—
|
|
Post-training Metabolism: C-reactive Protein (CRP)
Post-training
|
4.545 mg/L
Standard Deviation 2.581
|
—
|
PRIMARY outcome
Timeframe: BaselinePopulation: This outcome measure pertained only to the Training Study: Low Frequency arm and to the Comparator Cohort. 11 participants in the Training study: low frequency arm contributed PROMIS subject-report measures.
Pre-training Patient Reported Outcomes Measurement Information Systems (PROMIS) Global Health - Physical health T-score Theoretical minimum = 16.2, Theoretical maximum = 67.7, higher scores signify more of the construct being measured (eg. physical health). US population mean = 50, SD = 10.
Outcome measures
| Measure |
Acute Gene Regulation: Low Frequency
n=11 Participants
Adaptations in gene regulation in response to single-session low-frequency exercise.
Low-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of low-frequency electrical stimulation.
|
Acute Gene Regulation: High Frequency
n=18 Participants
Adaptations in gene regulation in response to single-session high-frequency exercise.
High-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of high-frequency electrical stimulation.
|
|---|---|---|
|
Pre-training Subject-report Measures: PROMIS Physical Health
|
39.9 T-score
Standard Deviation 4.9
|
37.0 T-score
Standard Deviation 4.1
|
PRIMARY outcome
Timeframe: BaselinePopulation: This outcome measure pertained only to the Training Study: Low Frequency arm and to the Comparator Cohort. 11 participants in the Training study: low frequency arm contributed PROMIS subject-report measures.
Pre-training Patient Reported Outcomes Measurement Information Systems (PROMIS) Global Health - Mental health T-score Theoretical minimum = 21.2, Theoretical maximum = 67.6, higher scores signify more of the construct being measured (eg. mental health). US population mean = 50, SD = 10.
Outcome measures
| Measure |
Acute Gene Regulation: Low Frequency
n=11 Participants
Adaptations in gene regulation in response to single-session low-frequency exercise.
Low-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of low-frequency electrical stimulation.
|
Acute Gene Regulation: High Frequency
n=18 Participants
Adaptations in gene regulation in response to single-session high-frequency exercise.
High-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of high-frequency electrical stimulation.
|
|---|---|---|
|
Pre-training Subject Report Measures: PROMIS Mental Health
|
47.0 T-score
Standard Deviation 5.1
|
47.3 T-score
Standard Deviation 4.1
|
PRIMARY outcome
Timeframe: 6 monthsPopulation: This outcome measure pertained only to the Training Study: Low Frequency arm. 11 participants contributed PROMIS subject-report measures.
Pre- and post-training Patient Reported Outcomes Measurement Information Systems (PROMIS) Global Health - Physical health T-score Theoretical minimum = 16.2, Theoretical maximum = 67.7, higher scores signify more of the construct being measured (eg. physical health). US population mean = 50, SD = 10.
Outcome measures
| Measure |
Acute Gene Regulation: Low Frequency
n=11 Participants
Adaptations in gene regulation in response to single-session low-frequency exercise.
Low-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of low-frequency electrical stimulation.
|
Acute Gene Regulation: High Frequency
Adaptations in gene regulation in response to single-session high-frequency exercise.
High-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of high-frequency electrical stimulation.
|
|---|---|---|
|
Post-training Subject-report Measures: PROMIS Physical Health
Pre-training
|
39.9 T-score
Standard Deviation 4.9
|
—
|
|
Post-training Subject-report Measures: PROMIS Physical Health
Post-training
|
39.5 T-score
Standard Deviation 5.6
|
—
|
PRIMARY outcome
Timeframe: 6 monthsPopulation: This outcome measure pertained only to the Training Study: Low Frequency arm. 11 participants contributed PROMIS subject-report measures.
Pre- and post-training Patient Reported Outcomes Measurement Information Systems (PROMIS) Global Health - Mental health T-score Theoretical minimum = 21.2, Theoretical maximum = 67.6, higher scores signify more of the construct being measured (eg. mental health). US population mean = 50, SD = 10.
Outcome measures
| Measure |
Acute Gene Regulation: Low Frequency
n=11 Participants
Adaptations in gene regulation in response to single-session low-frequency exercise.
Low-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of low-frequency electrical stimulation.
|
Acute Gene Regulation: High Frequency
Adaptations in gene regulation in response to single-session high-frequency exercise.
High-frequency Exercise: The quadriceps/hamstrings will perform exercise via the application of high-frequency electrical stimulation.
|
|---|---|---|
|
Post-training Subject-report Measures: PROMIS Mental Health
Pre-training
|
47.0 T-score
Standard Deviation 5.1
|
—
|
|
Post-training Subject-report Measures: PROMIS Mental Health
Post-training
|
47.3 T-score
Standard Deviation 5.1
|
—
|
Adverse Events
Acute Gene Regulation: Low Frequency
Acute Gene Regulation: High Frequency
Training Study: Low Frequency
Training Study: High Frequency
Comparator Cohort
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Dr. Richard K. Shields
University of Iowa Department of Physical Therapy and Rehabilitation Science
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place